Gufic BioSciences Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹231.41 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.38 per cent from ₹237.05 crore. This corresponds to a year-on-year *(YoY) growth of 11.37 per cent.
Operating Profit
Operating Profit stands at ₹32.98 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.84 per cent from ₹37.84 crore. This corresponds to a year-on-year *(YoY) decline of 2.77 per cent.
PBDT
PBDT stands at ₹25.41 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 16.33 per cent from ₹30.37 crore. This corresponds to a year-on-year *(YoY) decline of 17.74 per cent.
Profit Before Tax
Profit Before Tax stands at ₹17.72 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 21.59 per cent from ₹22.60 crore. This corresponds to a year-on-year *(YoY) decline of 32.55 per cent.
Net Profit
Net Profit stands at ₹12.42 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 26.16 per cent from ₹16.82 crore. This represents a 35.68 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Gufic BioSciences Ltd Earnings
- YOY
- QOQ
Gufic BioSciences Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Gufic BioSciences Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Gufic BioSciences Ltd Financial Reports
Gufic BioSciences Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Gufic BioScience | 1.99% | -0.26% | 14.11% | 16.71% | -7.37% | -16.73% |
| Novartis India | 5.21% | 9.28% | 44.06% | 61.71% | 83.49% | 42.85% |
| Aarti Drugs | -1.10% | -0.89% | 4.15% | 9.24% | -6.13% | -12.21% |
| SMS Pharma. | 0.04% | 2.12% | -6.54% | 2.20% | 20.63% | 42.95% |
| Dishman Carbogen | -1.40% | -1.00% | 7.68% | 14.81% | -16.93% | -25.69% |
| Hikal | 0.64% | 3.16% | 16.09% | 14.58% | -2.39% | -40.86% |
| Solara Active | -2.71% | -1.51% | 9.68% | 18.26% | 5.12% | 13.77% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Jayesh P Choksi
ED / WTD / CEO / Promoter : Pranav J Choksi
Whole-time Director : Pankaj Gandhi
Independent Non Exe. Director : Anusanjiv Aurora
Independent Non Exe. Director : Kamal Kishore Seth
Independent Non Exe. Director : Akshya Kumar Mahapatra
Company Sec. & Compli. Officer : Ami Naresh Shah